# Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

> **NCT00454272** · PHASE4 · COMPLETED · sponsor: **Sanofi** · enrollment: 197 (actual)

## Conditions studied

- Infection
- Febrile Neutropenia

## Interventions

- **DRUG:** Teicoplanin
- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT00454272
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2009-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00454272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00454272, "Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00454272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*